Intravenous Administration of Glutamate Ionotropic Antagonists in Healthy Rats, Induces Lymphopenia and Affects Their Hematological Profile

Aliki Xochelli, Dorothea Kapoukranidou, Maria Kritsepi-Konstantinou, Vassilia Garipidou, Anastastios Kourkoutelis, Konstantinos Kallaras, Maria Albani

Abstract


Background: Glutamate is one of the primary endogenous amino acids of the Central Nervous System (CNS). Research over the last years has proven the existence of glutamate subunit receptors in additional non-neuronal tissues outside CNS such as the hematopoietic system.The purpose of this paper is to define the possible in vivo effect of glutamate ionotropic antagonists MK-801and NBQX in the hematopoietic system as well as their possible use in the cure of hematopoietic diseases and on their use on patients with co-existing neurological and hematopoietic disorders.

Methods: Glutamate ionotropic antagonists MK-801 and NBQX were administrated intravenously in male wistar rats of 250 - 350 g weight. Animals treated with glutamate antagonists (n = 24) were compared to a control group (n = 10). The following parameters were evaluated 12 h and 24 h after drug administraton: Full blood count with differential, aggregation intensity, plus CD3, CD54 and CD49a expression on T-lymphocytes with flow cytometry. Bone marrow was assessed with bone marrow smears. The results were analyzed by unpaired t-test.

Results: Both ionotropic antagonists reduced white blood cells with early lymphopenia (P less than 0.05), whereas NBQX also increased Ht and Hb values (P < 0.05), but reduced platelet aggregation (P less than 0.05). T-cell surface activation markers, CD3, CD49a were reduced (P less than 0.05), whereas CD54 was increased (P less than 0.05) 12 h after both antagonists’ administration but 24 h after NBQX all markers were increased (P less than 0.05). Bone marrow cells were influenced in a way that peripheral blood changes and segmented cells showed a possible expression of glutamate receptors.

Conclusions: It is concluded that glutamate ionotropic antagonists affect the hematological profile and bone marrow of healthy intact rats as well as blood elements functions. Further research is needed in order to define the in vivo effect of glutamate and glutamate receptor antagonists on hematopoietic system either as a toxic agent or as a therapeutical one.




doi:10.4021/jh101e 


Keywords


NMDA; Glutamate; Bone marrow; Blood; Lymphocytes; Megakaryocytes

Full Text: HTML PDF
 
Home     |     Log In     |      About     |      Search     |      Current     |      Archives     |      Submit      |     Subscribe


 

     

Aims and Scope

Current Issues

Conflict of Interest

About Publisher

Editorial Board

Archives

Copyright

Company Profile

Editorial Office

Misconduct and Retraction

Permissions

Company Registration

Contact Us

Abstracting and Indexing

ICMJE

Ownership

Instructions to Authors

Access

Declaration of Helsinki

Contact Publisher

Submission Checklist

Reprints

Terms of Use

Company Address

Submit a Manuscript

Open Access Policy

Privacy Policy

Browse Journals

Publishing Fee

Publishing Policy

Disclaimer

Recent Highlights

Peer-Review Process

Publishing Quality

Code of Ethics

Advertising Policy

Manuscript Tracking

Advanced Search

For Librarians

Careers

Publishing Process

Publication Frequency

For Reviewers

Propose a New Journal

       
       

Journal of Hematology, quarterly, ISSN 1927-1212 (print), 1927-1220 (online), published by Elmer Press Inc.            
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC BY-NC 4.0)



This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.thejh.org    editorial contact: editor@thejh.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada
 

© Elmer Press Inc. All Rights Reserved.

IMPORTANT: THIS JOURNAL SITE OUTLOOK IS DESIGNED BY THE PUBLISHER AND COPYRIGHT PROTECTED. DO NOT COPY!